Foghorn Therapeutics
Dan Dinu is a seasoned IT leader with extensive experience in various roles within the technology sector. Currently serving as Vice President and Head of IT at Foghorn Therapeutics Inc. since January 2020, Dan has a proven track record in leading IT functions. Prior to this, Dan held multiple leadership positions at PA Consulting Group, where responsibilities included developing IT strategies for biotech firms and improving operational efficiency in contract research organizations. Dan's career includes roles at accend IT Consulting, where international expansion of web platforms was managed, and at anwalt.de services AG, where systems for accounts receivables and e-payment activities were implemented. Early career experiences at Siemens AG and Siemens Healthcare involved consultancy projects focused on market analysis and system development. Dan holds an MBA and a Master of Science in Information Systems from Questrom School of Business, Boston University, alongside a Diploma in Business from Technische Hochschule Nürnberg Georg Simon Ohm.
Foghorn Therapeutics
1 followers
Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Their proprietary Gene Traffic Control platform gives them an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing them to identify, validate, and potential drug targets within the system.